Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
Barriers and opportunities for a complementary medicine advisory network in pediatric oncology: perspectives from
Lara Nowak1, Daniela Reis1,2, David D Martin2,3
1Department of Pediatrics, Gemeinschaftskrankenhaus Herdecke, Herdecke, Germany.
Abstract:
Complementary medicine (CM) is commonly used by parents of pediatric cancer patients alongside conventional treatment, yet pediatric oncologists often feel inadequately trained to advise on CM. A collaborative project led by Gemeinschaftskrankenhaus Herdecke, integrated into inpatient pediatric cancer care in four centers in Germany in the Rhine-Ruhr Region, provides CM consultations and training for pediatric oncology teams. This study aimed to identify barriers perceived by healthcare professionals regarding the implementation of a CM advisory network for parents and assess their training needs. Eleven semi-structured interviews, lasting an average of 17.6 min, were conducted at four locations, including in-person (n = 7) and digital (n = 5) formats. Participants included physicians, senior physicians, residents and nurses. The interviews were analyzed using qualitative thematic analysis to inform targeted training for healthcare professionals to promote safe use of CM. The results highlighted the relevance of CM as perceived by healthcare professionals, as parents expect it to support their child's therapy. There was a notable interplay between parents' desire to explore options beyond conventional treatment and the stress they experience due to their child's diagnosis. The study identified necessary features for implementing a counseling service, emphasizing further training options, consistency, and identifying additional options. For team training, the interviewees stressed the importance of practical orientation and self-exploration. The key barriers identified were the scarcity of resources, including personnel, time, costs, and logistics. The study's findings will inform the development of future educational interventions for healthcare professionals.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers